Voya Investment Management LLC Biotechnology

Voya Investment Management LLC

$79.9 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
VRTX Vertex Pharmaceuticals Inc	$110B	$436 Million 0.55% of portfolio	938,051	Q1 2024 Added 0.15%
REGN Regeneron Pharmaceuticals, Inc.	$72.9B	$197 Million 0.25% of portfolio	187,280	Q1 2024 Reduced 55.77%
INSM Insmed Inc	$10.6B	$53.5 Million 0.07% of portfolio	732,753	Q1 2024 Reduced 36.97%
VKTX Viking Therapeutics, Inc.	$2.61B	$42.7 Million 0.05% of portfolio	674,139	Q1 2024 Added 58.51%
PCVX Vaxcyte, Inc.	$5.14B	$33.6 Million 0.04% of portfolio	293,948	Q1 2024 Reduced 37.7%
TECH Bio Techne Corp	$3.09B	$32.5 Million 0.04% of portfolio	407,192	Q1 2024 Reduced 52.43%
ALNY Alnylam Pharmaceuticals, Inc.	$32.8B	$29.9 Million 0.04% of portfolio	108,709	Q1 2024 Reduced 35.15%
SRPT Sarepta Therapeutics, Inc.	$10.2B	$28.1 Million 0.04% of portfolio	225,039	Q1 2024 Added 50.03%
ABCL Ab Cellera Biologics Inc.	$1.01B	$27.5 Million 0.03% of portfolio	10,624,185	Q3 2024 Reduced 0.08%
SWTX Spring Works Therapeutics, Inc.	$2.18B	$23.1 Million 0.03% of portfolio	722,065	Q1 2024 Reduced 19.66%
HALO Halozyme Therapeutics, Inc.	$7.7B	$21.3 Million 0.03% of portfolio	372,470	Q1 2024 Reduced 30.18%
MLTX Moon Lake Immunotherapeutics	$1.69B	$20.6 Million 0.03% of portfolio	409,203	Q1 2024 Reduced 84.42%
CRNX Crinetics Pharmaceuticals, Inc.	$2.08B	$19.3 Million 0.02% of portfolio	377,589	Q1 2024 Reduced 86.95%
BPMC Blueprint Medicines Corp	$6.63B	$16.4 Million 0.02% of portfolio	177,820	Q1 2024 Reduced 42.03%
RNA Avidity Biosciences, Inc.	$1.57B	$15.3 Million 0.02% of portfolio	332,983	Q1 2024 Reduced 92.64%
FOLD Amicus Therapeutics, Inc.	$2.68B	$14.8 Million 0.02% of portfolio	1,389,246	Q1 2024 Reduced 25.66%
RVMD Revolution Medicines, Inc.	$3.59B	$13.7 Million 0.02% of portfolio	302,892	Q1 2024 Reduced 6.36%
UTHR United Therapeutics Corp	$16.9B	$13.2 Million 0.02% of portfolio	36,967	Q1 2024 Reduced 17.69%
KRYS Krystal Biotech, Inc.	$3.94B	$12.4 Million 0.02% of portfolio	68,444	Q1 2024 Reduced 13.83%
ADMA Adma Biologics, Inc.	$3.23B	$12.1 Million 0.02% of portfolio	604,994	Q1 2024 Reduced 88.24%
ACLX Arcellx, Inc.	$2.92B	$11.9 Million 0.01% of portfolio	143,093	Q1 2024 Added 165.79%
NUVL Nuvalent, Inc.	$3.49B	$11 Million 0.01% of portfolio	107,399	Q1 2024 Added 112.4%
IDYA Ideaya Biosciences, Inc.	$1.11B	$10.3 Million 0.01% of portfolio	325,808	Q1 2024 Reduced 44.16%
MRNA Moderna, Inc.	$15.1B	$10.2 Million 0.01% of portfolio	152,415	Q1 2024 Added 62.99%
EXEL Exelixis, Inc.	$10.6B	$10 Million 0.01% of portfolio	386,699	Q1 2024 Added 25.32%
KROS Keros Therapeutics, Inc.	$293M	$9.94 Million 0.01% of portfolio	171,170	Q1 2024 Reduced 65.37%
CORT Corcept Therapeutics Inc	$6.32B	$9.79 Million 0.01% of portfolio	211,563	Q1 2024 Reduced 87.44%
NVO Novo Nordisk A S	$182B	$9.64 Million 0.01% of portfolio	80,941	Q1 2024 Added 57.35%
RARE Ultragenyx Pharmaceutical Inc.	$3.01B	$9 Million 0.01% of portfolio	162,093	Q1 2024 Reduced 36.79%
MDGL Madrigal Pharmaceuticals, Inc.	$5.55B	$8.95 Million 0.01% of portfolio	42,153	Q1 2024 Reduced 58.42%
DYN Dyne Therapeutics, Inc.	$730M	$8.92 Million 0.01% of portfolio	248,320	Q1 2024 Reduced 69.02%
INCY Incyte Corp	$16.1B	$8.26 Million 0.01% of portfolio	125,009	Q1 2024 Added 59.86%
AXSM Axsome Therapeutics, Inc.	$4.39B	$8.19 Million 0.01% of portfolio	91,155	Q1 2024 Reduced 78.84%
EWTX Edgewise Therapeutics, Inc.	$1.71B	$7.99 Million 0.01% of portfolio	299,369	Q1 2024 Reduced 93.89%
BCRX Biocryst Pharmaceuticals Inc	$1.42B	$6.72 Million 0.01% of portfolio	883,817	Q1 2024 Added 13.07%
BMRN Biomarin Pharmaceutical Inc	$11.5B	$6.35 Million 0.01% of portfolio	90,345	Q1 2024 Reduced 5.99%
CRMD Cor Medix Inc.	$506M	$5.75 Million 0.01% of portfolio	711,949	Q1 2024 Reduced 97.28%
SMMT Summit Therapeutics Inc.	$4.71B	$5.64 Million 0.01% of portfolio	257,531	Q1 2024 Reduced 84.68%
ARWR Arrowhead Pharmaceuticals, Inc.	$2.09B	$5.61 Million 0.01% of portfolio	289,699	Q1 2024 Reduced 37.21%
RYTM Rhythm Pharmaceuticals, Inc.	$3.21B	$5.39 Million 0.01% of portfolio	102,832	Q1 2024 Added 65.04%
ARGX Argenx Se	$35.4B	$5.2 Million 0.01% of portfolio	9,585	Q1 2024 Reduced 1.3%
PTGX Protagonist Therapeutics, Inc	$1.81B	$5.12 Million 0.01% of portfolio	113,852	Q1 2024 Reduced 39.01%
VERA Vera Therapeutics, Inc.	$913M	$4.57 Million 0.01% of portfolio	103,409	Q1 2024 Reduced 1.2%
JAZZ Jazz Pharmaceuticals PLC	$7.57B	$3.96 Million 0.0% of portfolio	35,556	Q1 2024 Added 26.51%
IONS Ionis Pharmaceuticals Inc	$4.61B	$3.84 Million 0.0% of portfolio	95,821	Q1 2024 Reduced 43.44%
MNKD Mannkind Corp	$1.59B	$3.79 Million 0.0% of portfolio	603,615	Q1 2024 Added 70.55%
CYTK Cytokinetics Inc	$4.41B	$3.71 Million 0.0% of portfolio	70,216	Q1 2024 Added 299.78%
JANX Janux Therapeutics, Inc.	$1.67B	$3.17 Million 0.0% of portfolio	69,801	Q1 2024 Reduced 41.76%
TVTX Travere Therapeutics, Inc.	$1.25B	$3.11 Million 0.0% of portfolio	222,470	Q1 2024 Reduced 6.6%
KYMR Kymera Therapeutics, Inc.	$2.41B	$2.94 Million 0.0% of portfolio	62,177	Q1 2024 Added 13.29%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.